SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
HRUSOVSKY E KEVIN
(Last) (First) (Middle)
68 ELM STREET
(Street)
HOPKINTON MA 01748
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CALIPER LIFE SCIENCES INC [ CALP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/09/2011
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 10/31/2011 10/31/2011 M 69,529 A $5.46 826,725 D
Common Stock(1) 10/31/2011 10/31/2011 M 18,482 A $5.85 757,196 D
Common Stock(1) 10/31/2011 10/31/2011 M 9,460 A $6.25 738,714 D
Common Stock(1) 10/31/2011 10/31/2011 M 16,363 A $6.4 729,254 D
Common Stock(1) 10/31/2011 10/31/2011 M 21,005 A $5.69 712,891 D
Common Stock(1) 10/31/2011 10/31/2011 M 7,060 A $4.09 691,886 D
Common Stock(1) 10/31/2011 10/31/2011 M 8 A $1.3 684,826 D
Common Stock(1) 10/31/2011 10/31/2011 M 37,500 A $3.42 684,818 D
Common Stock(2) 08/09/2011 08/09/2011 M 2,472 A $6.79 647,318 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (Right to Buy) $5.46 10/31/2011 10/31/2011 M 69,529 07/14/2004(3) 07/13/2013 Common Stock 69,529 $0.00 630,471 D
Option (Right to Buy) $5.85 10/31/2011 10/31/2011 M 18,482 07/30/2005(4) 07/29/2014 Common Stock 18,482 $0.00 61,518 D
Option (Right to Buy) $6.25 10/31/2011 10/31/2011 M 9,460 08/17/2006(5) 08/16/2015 Common Stock 9,460 $0.00 30,540 D
Option (Right to Buy) $6.4 10/31/2011 10/31/2011 M 16,363 03/29/2007(6) 03/28/2016 Common Stock 16,363 $0.00 112,637 D
Option (Right to Buy) $5.69 10/31/2011 10/31/2011 M 21,005 04/04/2008(7) 04/03/2017 Common Stock 21,005 $0.00 78,995 D
Option (Right to Buy) $4.09 10/31/2011 10/31/2011 M 7,060 03/06/2009(8) 03/05/2018 Common Stock 7,060 $0.00 192,940 D
Option (Right to Buy) $1.3 10/31/2011 10/31/2011 M 8 03/03/2010(9) 03/02/2019 Common Stock 8 $0.00 199,992 D
Option (Right to Buy) $3.42 10/31/2011 10/31/2011 M 37,500 02/23/2011(10) 02/23/2020 Common Stock 37,500 $0.00 62,500 D
Common Stock Purchase Warrants $6.79 08/09/2011 08/09/2011 M 2,472 08/09/2006 08/09/2011 Common Stock 2,472 $0.00 0 D
Explanation of Responses:
1. Represents shares of Caliper Common Stock received upon exercise, on October 31, 2011, of vested incentive stock options held by Mr. Hrusovsky as shown in Table II.
2. On August 9, 2011, Mr. Hrusovsky exercised Caliper warrants which he had received on August 9, 2006, in exchange for Xenogen Common Stock that was issued to him as director compensation as a former non-employee director of Xenogen Corporation prior to Xenogen's merger with Caliper.
3. 25% of the shares subject to the original grant of 700,000 options vest one year from date of grant (July 14, 2004) and 1/48th of the shares subject to the option vest monthly thereafter.
4. The original grant of 80,000 options became exercisable with respect to 25% of the option shares on July 30, 2005 and the balance of the option shares vest in a series of 12 successive equal quarterly installments over the 36-month period thereafter.
5. The original grant of 40,000 options became exercisable with respect to 25% of the option shares on August 17, 2006 and the balance of the option shares vest in a series of 12 successive equal quarterly installments over the 36-month period thereafter.
6. The original grant of 129,0000 options became exercisable with respect to 25% of the option shares on March 29, 2007 and the balance of the option shares vest in a series of 12 successive equal quarterly installments over the 36-month period thereafter.
7. The original grant of 100,000 options became exercisable with respect to 25% of the option shares on April 4, 2008 and the balance of the option shares vest in a series of 12 successive equal quarterly installments over the 36-month period thereafter.
8. The original grant of 200,000 options became exercisable with respect to 25% of the option shares on March 06, 2009 and the balance of the option shares in a series of 12 successive equal quarterly installments over the three-year period thereafter.
9. The original grant of 200,000 options became exercisable with respect to 25% of the option shares on March 03, 2010 and the balance of the option shares in a series of 12 successive equal quarterly installments over the three-year period thereafter.
10. The original grant of 100,000 options became exercisable with respect to 25% of the option shares on February 23, 2011 and the balance of the option shares vest in a series of 12 successive equal quarterly installments over the three-year period thereafter.
Remarks:
/s/ Peter F. McAree Attorney-In-Fact 11/02/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.